Home › Meningioma › Arizona › Phoenix
Meningioma clinical trials in Phoenix, AZ
4 studies for Meningioma are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- Mayo Clinic_Arizona, Phoenix
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Cancer Center at Saint Joseph's, Phoenix
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- HonorHeath Scottsdale Osborn Medical Center, Phoenix
Abemaciclib in Newly Diagnosed Meningioma Patients
RecruitingPhase 2
- St. Joseph's Hospital and Medical Center, Phoenix
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL8 studies
- Columbus, OH7 studies
- Boston, MA7 studies
- Atlanta, GA6 studies
- San Francisco, CA6 studies
- Jacksonville, FL5 studies
- San Diego, CA5 studies
- Houston, TX4 studies
- St. Louis, MO4 studies
- Arlington, VA4 studies
- Los Angeles, CA4 studies
Other studies in Phoenix
- Colorectal Cancer25 studies
- Breast Cancer25 studies
- Obesity23 studies
- Metastatic Cancer20 studies
- Non-Small Cell Lung Cancer20 studies
- Heart Failure18 studies
- Pancreatic Cancer17 studies
- Cancer (all types)17 studies
- Prostate Cancer17 studies
- Multiple Myeloma16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.